Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Innate Pharma Sa Class A.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:04.653 Hello, and thank you for standing by. My name is Lacey, and I will be your conference 00:00:04.653 -- 00:00:09.675 operator today. At this time, I would like to welcome everyone to the Innate Pharma 00:00:09.675 -- 00:00:15.377 First Quarter 2025 Financial Results and Business Update Conference Call. 00:00:15.377 -- 00:00:18.899 All lines have been placed on mute to prevent any background noise. 00:00:18.899 -- 00:00:22.340 After speaker remarks, there will be a question and answer session. 00:00:22.340 -- 00:00:26.582 If you would like to ask a question during this time, simply press star followed by the 00:00:26.582 -- 00:00:31.528 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:31.528 -- 00:00:36.530 star 1 again. Thank you. I would now like to turn the call over to 00:00:36.530 -- 00:00:39.971 Henry Wheeler, Vice President of Investor and Relations. 00:00:39.971 -- 00:00:42.272 You may go ahead. 00:00:42.272 -- 00:00:46.133 Thank you. Good morning, good afternoon, and welcome, everyone. 00:00:46.133 -- 00:00:51.155 This morning, Innate issued a press release for our Q1 2025 business update and financial 00:00:51.155 -- 00:00:55.774 results. We look forward to highlighting the progress made during the year to date, as 00:00:55.774 -- 00:00:57.756 well as addressing future goals and milestones. 00:00:57.756 -- 00:01:02.159 The press release and today's presentation are both available on the IR section of our 00:01:02.159 -- 00:01:03.621 website. 00:01:03.621 -- 00:01:07.144 On slide two, before we start, I'd like to remind you that we'll be making forward-looking 00:01:07.144 -- 00:01:10.967 statements regarding the financial outlook in addition to regulatory and product plan 00:01:10...